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Abstract
Recently, a series of genome editing technologies including ZFNs, TALENs, and 
CRISPR/Cas9 systems have enabled gene modification in the endogenous target 
genes of various organisms including pigs, which are important for agricultural and 
biomedical research. Owing to its simple application for gene knockout and ease 
of use, the CRISPR/Cas9 is now in common use worldwide. The most important 
aspect of this process is the selection of the method used to deliver genome editing 
components to embryos. In earlier stages, zygote microinjection of these compo-
nents [single guide RNA (sgRNA) + DNA/mRNA for Cas9] into the cytoplasm and/
or nuclei of a zygote has been frequently employed. However, this method is always 
associated with the generation of mosaic embryos in which genome-edited and 
unedited cells are mixed together. To avoid this mosaic issue, in vitro electropora-
tion of zygotes in the presence of sgRNA mixed with Cas9 protein, referred to as a 
ribonucleoprotein (RNP), is now in frequent use. This review provides a historical 
background of the production of genome-edited pigs and also presents current 
research concerning how genome editing is induced in somatic cell nuclear transfer-
derived embryos that have been reconstituted with normal nuclei.
Keywords: genome editing, CRISPR/Cas9, ZFNs, TALENs, pigs, gene modification, 
microinjection, electroporation, somatic cell nuclear transfer, knock out, knock in, 
gene-engineered, ribonucleoprotein
1. Introduction
The domestic pig has been widely used as a large animal model in biomedical 
research, as it is similar to humans with respect to the size of body and internal 
organs, longevity, anatomy, physiology, and metabolic profile [1]. Modification 
of the porcine genome is also important for studying the mechanisms underlying 
genetic disorders, developing therapeutic drugs, and improving pig meat production 
yields [2, 3]. Over the past three decades, attempts have been made to modify the 
porcine genome using genetic engineering technology, starting after Gordon et al. 
[4] first reported DNA microinjection (MI)-based production of transgenic (Tg) 
mice. Hammer et al. [5] first reported the successful production of Tg piglets using 
the technique reported by Gordon et al. [4], but attaining this result was more diffi-
cult than for rodents, where pronuclei are clearly visible using an optical microscope. 
Reproductive Biology and Technology in Animals
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In the case of porcine zygotes, pronuclei are difficult to see due to the presence of 
high lipid content in the cytoplasm. Researchers must briefly centrifuge zygotes 
to visualize the pronuclei prior to MI [5], which is labor-intensive and requires 
skill. Moreover, MI-mediated transgene integration into host chromosomes occurs 
randomly, which often causes gene silencing [6]. However, for precise and efficient 
genetic modification in the porcine genome, homologous recombination (HR)-based 
gene targeting technology may be recommended, which was first developed by 
Smithies’ group in mice [7]. In this case, the use of germline-competent embryonic 
stem (ES) cells is a prerequisite. These ES cells are first transfected with a targeting 
vector and then recombinant ES clones showing successful targeting are obtained. 
This vector usually contains a gene of interest (GOI) to be integrated into the target 
locus, together with a selection marker gene such a neomycin resistance gene (neo), 
and DNA sequences of appropriate length, termed homology arms (HA), that corre-
spond to the endogenous target gene, are placed at both ends of the DNA containing 
the GOI and a marker gene. Chimeric mice can be obtained through blastocyst injec-
tion with the targeted ES clones, and the resulting chimeric mice would contribute 
to produce heterozygous mice carrying mutated traits (GOI/selection marker gene) 
in the target locus [8]. Unfortunately, there are no germline-competent porcine ES 
cells, despite extensive efforts [9–13]. Thus, to date, production of gene-targeted pigs 
derived from recombinant porcine ES cells has not yet been successful.
In 1996, scientists at the Roslin Institute (Wilmut and colleagues) first succeeded 
in producing cloned sheep using somatic cell nuclear transfer (SCNT) technology. 
They used fetal fibroblasts [14] or adult mammary gland-derived fibroblasts [15] 
as SCNT donors. Notably, prior to these reports, an attempt to produce cloned 
embryos by the similar technique shown by the Roslin’s group has been made by 
Prather et al. [16], who performed transfer of nuclei from two, four and eight-cell 
embryos to the enucleated oocytes and successfully produced one piglets that had 
been derived from the four-cell embryo’s nucleus. This approach is called “blas-
tomere transplantation,” which is basically different from the somatic cell-based 
SCNT. Generally, fibroblasts used as SCNT donors can proliferate actively in vitro, 
and therefore are considered to be ideal cells for transgenesis or gene targeting. 
If these engineered fibroblasts are used for SCNT, the resulting cloned embryos 
and piglets should have the engineered traits in their genome. This possibility was 
first proven by the scientists at the Roslin Institute [17, 18] who successfully produced 
genetically engineered (GE) cloned sheep through SCNT using GE fetal fibroblasts. 
Since then, SCNT using GE cells as SCNT donors has been a common approach for 
production of knockout (KO) or Tg piglets [19, 20]. However, as mentioned below, 
the efficiency of producing cloned GE piglets is extremely low and the prepara-
tion of GE donor cells is laborious and time-consuming [21]. During the past two 
decades, production of only a few GE (KO) piglets has been reported by traditional 
approaches [22–27]. Moreover, almost all resulting KO piglets were heterozygous 
with respect to the KO allele, thus requiring additional tasks such as breeding (likely 
one or two generations), sequence targeting, or in vitro cell cloning to obtain homo-
zygous KO animals [28], which is also laborious, expensive, and time-consuming.
However, this situation drastically changed when new gene-targeting technologies 
emerged for precisely manipulating mammalian genomes, called “second-generation 
genome editing.” These technologies require the design of site-specific engineered 
nucleases which can be zinc-finger nucleases (ZFNs), transcription activator-like 
effector nucleases (TALENs) or clustered regularly interspaced short palindromic 
repeat-associated protein 9 (CRISPR/Cas9) nucleases, all of which induce a double-
stranded break (DSB) at a specific site in the genome. This DSB facilitates genetic 
modification such as nonhomologous end-joining (NHEJ) and homology directed 
repair (HDR) [29], as described below. Using these genome-editing systems, many 
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GE piglets have been produced using SCNT of genome-edited cells, or direct micro-
injection of genome-editing components (including engineered endonucleases) into 
the cytoplasm of zygotes, as described below in more detail.
2. Background of second-generation genome editing
As mentioned above, site-specific engineered nucleases are used in these 
genome-editing techniques. ZFNs, TALENs, and CRISPR/Cas9 can all bind to DNA 
and induce DSB, which triggers endogenous DNA repair. If the template DNA is 
absent, the DSB is repaired via the NHEJ pathway where insertion or deletion of 
nucleotides (hereinafter called “indels”) can happen in the cleaved area. These 
indels often cause frameshift of the amino acid sequence, leading to the generation 
of abnormal proteins or formation of a premature stop codon leading to cessation 
of protein synthesis. If template DNA homologous to the target site is present, 
it is inserted into the cleaved area via a site-specific HR event which is called 
HDR. Generally, NHEJ occurs in cells independent of its cell cycle, but HDR occurs 
primarily in dividing cells [30].
The ZFN technique uses the ZF protein (which binds to the target DNA) and the 
endonuclease Fok I (which cleaves DNA) [31]. ZF protein has several protein motifs 
capable of recognizing specific sequences of three nucleotides and binding to them. 
Notably, Urnov et al. [32] first demonstrated that ZFN is effective to induce DNA 
editing at the endogenous target gene in mammalian cells. Its targeting efficiency 
was over 18% in the absence of drug selection, which is ~1000-fold higher than that 
achieved by traditional gene targeting.
The TALEN technique uses proteins, termed transcription activator-like effec-
tors (TALEs), which contain 33–35 amino acid repeats that flank a central DNA 
binding region (amino acids 12 and 13), and Fok I nuclease, as in ZFN, thus the term 
TALE nucleases (TALENs) [33–35]. Notably, the design and engineering of TALENs 
is simpler than that of ZFN, and thus can be done faster [35, 36].
CRISPR/Cas9 employs a short (20 bp) RNA sequence called single-guide RNA 
(sgRNA) which can bind to the specific chromosomal DNA site together with the 
Cas9 endonuclease [37–40]. Once bound, two independent nuclease domains in 
Cas9 each cleave one of the DNA strand’s three bases upstream of the protospacer 
adjacent motif (PAM), introducing DSB at the target site of the host chromosome, 
which is then repaired by NHEJ. This system is different from the other genome 
editing tools such as ZFNs and TALENs, and thus synthesis of sgRNA is a prereq-
uisite for this system. This development dramatically reduced both the complexity 
and time required for the design and implementation of gene editing.
3. History of GE in pigs
Table 1 lists instances of production of GE piglets with genome editing technol-
ogy from 2011 to 2018. This section provides a brief explanation on the background 
of GE pig production.
In 2011, three types of GE piglets were produced using ZFNs from different 
laboratories. All of these piglets were produced by SCNT using GE cells as a SCNT 
donor. The first report showing successful production of GE piglets involved the 
disruption of enhanced green fluorescent protein (EGFP) gene in a hemizygous 
manner. Whyte et al. [41] demonstrated that a ZFN pair efficiently inactivated the 
expression of EGFP that was integrated into the chromosomes of porcine fibro-
blasts via the NHEJ pathway with an efficiency of ~5%. From this experiment, it 
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Method Genome editing 
tool (mode for gene 
modification)
Method for gene modification Outcome Target gene References
SCNT ZFN (indels) Using adult porcine ear fibroblasts hemizygous for the 
eGFP transgene
Seven of nine embryos (Day 12) exhibited loss of 
fluorescence
eGFP transgene [41]
SCNT ZFN (indels) Using porcine fibroblasts transfected with ZFN 
plasmid
Of 10 live piglets delivered, two carried the predicted 
ZFN-induced mutation; lower expression of both 
PPAR-γ1 and PPAR-γ2 was observed in those clones
PPARγ [42]
SCNT ZFN (indels) Using porcine fetal fibroblasts transfected with ZFN 
plasmid
Of six fetuses, all completely lacked α-Gal epitopes GGTA1 [43]
MI TALEN (indels) Cytoplasmic MI of TALEN mRNA toward IVF-
derived zygotes
CI of TALEN mRNAs inducing gene KO in up to 75% 
of embryos; Of the 18 live-born clones, eight contained 
monoallelic mutations and 10 contained biallelic 
modifications of the LDLR gene
LDLR [44]
MI ZFN, TALEN (indels) Cytoplasmic MI of ZFN or TALEN mRNA toward in 
vivo fertilized zygotes
Of 39 piglets produced, eight carried TALEN-derived 
editing events (21%); of nine piglets produced, one 
carried an editing event at the ZFN target site (11%)
NF-kappaB 
subunit
[45]
SCNT TALENs (indels) Using porcine fetal fibroblasts transfected with 
TALEN plasmid
Three piglets with biallelic mutations of the GGTA1 
gene exhibited loss of α-Gal epitopes on the surface of 
cells
GGTA1 [46]
SCNT TALENs (indels/KI) Using porcine fibroblasts transfected with TALEN 
mRNA + ssODN
Of eight piglets born from DAZL-modified cells, three 
are still born; of the six piglets from APC-modified 
cells, only one alive
DAZL, APC [47]
SCNT ZFNs (indels) Using porcine fetal fibroblasts transfected with ZFN 
mRNA
The resulting IL2RG KO pigs completely lacked a 
thymus and were deficient in T and NK cells, similar to 
human X-linked SCID patients
IL2RG [48]
SCNT ZFN (indels) Using porcine adult liver-derived cells transfected 
with ZFN plasmid through the two-steps
Four viable and healthy cloned pigs obtained exhibited 
disruption of the GGTA1 and the CMAH loci
GGTA1, CMAH [49]
SCNT ZFN (KI) Using porcine fibroblast cells transfected with ZFN 
plasmid and donor DNA
Successfully produced healthy monoallelic/biallelic 
CMAH KO pigs
CMAH [50]
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Method Genome editing 
tool (mode for gene 
modification)
Method for gene modification Outcome Target gene References
SCNT/MI CRISPR/Cas9 (KI/
indels)
Using porcine fetal fibroblasts transfected with 
sgRNA-Cas9 plasmids + donor DNA/cytoplasmic MI 
of Cas9 mRNA/sgRNA toward IVF-derived zygotes
Of the CD163 recipients, five delivered healthy piglets 
by cesarean section; 12 of the 13 piglets contained either 
a biallelic or homozygous deletion of CD1D
eGFP, CD163, 
CD1D
[51]
MI CRISPR/Cas9 (indels) Cytoplasmic MI of Cas9 mRNA/sgRNA toward in 
vivo fertilized zygotes
Ten of 16 resulting piglets had indels with an efficiency 
of 63% and were comprised by cells with monoallelic 
mutant; they can be a model for von Willebrand disease
vWF [52]
SCNT CRISPR/Cas9 (indels) Using porcine fetal fibroblasts transfected with Cas9/
sgRNA expression plasmid
A total of three piglets were obtained; fibroblasts from 
all three animals were negative for class I SLA cell 
surface expression
class I MHC [53]
SCNT TALENs (indels) Using pig fetal fibroblasts transfected with TALEN 
plasmid
Of 27 live cloned piglets obtained, nine were targeted 
with biallelic mutations in RAG1, three were targeted 
with biallelic mutations in RAG2, and 10 were targeted 
with a monoallelic mutation in RAG2
RAG1, RAG2 [54]
SCNT ZFN (indels) Using pig fetal fibroblasts transfected with ZFN 
plasmid
Three GGTA1 null piglets showing loss of α-Gal epitope 
expression were born
GGTA1 [55]
SCNT CRISPR/Cas9 (indels) Using pig liver-derived cells transfected with two or 
three plasmids expressing Cas9 and sgRNA targeting 
to GGTA1, CMAH, or putative iGb3S genes
Of 10 fetuses obtained, five had mutations in both the 
GGTA1 and CMAH genes
GGTA1, CMAH, 
putative iGb3S
[56]
SCNT ZFNs (indels) Using pig fetal fibroblasts transfected with ZFN 
plasmid
The MSTN-mutant pigs grew normally, had increased 
muscle mass with decreased fat accumulation
MSTN [57]
SCNT TALENs (indels) Using pig liver-derived cells transfected with TALEN 
plasmid
Livers from ASGR1−/− pigs exhibit decreased human 
platelet uptake
ASGR1 [58]
SCNT ZFN/TALEN (indels) Using pig fetal fibroblasts transfected with TALEN or 
ZFN mRNA
One of the cloned pigs generated GalT/CMAH-double 
homozygous KO pigs
CMAH [59]
SCNT CRISPR/Cas9 (KI) Using pig fetal fibroblasts transfected with targeting 
donor vector and two expression vectors for sgRNA 
and Cas9
Highly efficient KI (up to 54%) was achieved after drug 
selection; one cloned piglet obtained showed correct 
targeting
H11 [60]
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Method Genome editing 
tool (mode for gene 
modification)
Method for gene modification Outcome Target gene References
SCNT CRISPR/Cas9 Using pig fetal fibroblasts transfected with sgRNA, 
Cas9 expression plasmids
Four cloned double KO piglets showing loss of 
expression for both PARK2 and PINK1 were produced
TYR, PARK2, 
PINK1
[61]
MI CRISPR/Cas9 (KI) Cytoplasmic MI of Cas9 mRNA + sgRNA + ssODN 
toward in vivo fertilized zygotes
Two live-born piglets obtained showed the white coat-
color phenotype over its entire body
MITF [62]
MI CRISPR/Cas9 (KI) Cytoplasmic MI of Cas9 mRNA + sgRNA + circular 
vector toward in vivo fertilized zygotes
All 16 piglets born were healthy and carried the 
expected KI allele; the KI allele was successfully 
transmitted through germline
Alb [63]
MI CRISPR/Cas9 (indels) Cytoplasmic MI of Cas9 mRNA and sgRNA toward in 
vivo fertilized zygotes
Bi-allelic modifications of pig Npc1l1 were achieved at 
the efficiency as high as 100%
Npc1l1 [64]
SCNT CRISPR/Cas9 (indels) Using pig fetal fibroblasts transfected with sgRNA-
Cas9 encoding vector
Of eight marker-gene-free cloned pigs with biallelic 
mutations obtained, some showed phenotypes similar 
to DM
MSTN [65]
SCNT CRISPR/Cas9 (indels) Using liver-derived cells transfected with sgRNA-
Cas9 encoding vectors
One triple knockout pig was obtained; Cells from this 
cloned pig exhibited reduced human IgM and IgG 
binding
GGTA1, CMAH, 
β4GalNT2
[66]
SCNT CRISPR/Cas9 (indels) Using pig fetal fibroblasts transfected with sgRNA-
Cas9 encoding vector
Three cloned piglets with biallelic mutation produced 
showed no antibody-producing B cells
IgM JH [67]
EP CRISPR/Cas9 (indels) Using Cas9 protein and sgRNA (RNP) toward IVF-
derived zygotes
The use of gene editing by electroporation of Cas9 
protein (GEEP) resulted in highly efficient targeted 
gene disruption and efficient production of Myostatin 
mutant pigs
MSTN [68]
MI CRISPR/Cas9 (indels) Cytoplasmic MI of Cas9 mRNA and sgRNA toward in 
vivo fertilized zygotes
Of two piglets obtained, one piglets exhibited DMD 
phenotype, as exemplified by degenerative and 
disordered skeletal and cardiac muscle
DMD [69]
SCNT ZFN (indels) Using pig fetal fibroblasts transfected with ZFN-
encoding mRNA
The heterozygous FBN1 mutant pigs obtained exhibited 
abnormal phenotype, which resembles MFS found in 
humans
FBN1 [70]
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Method Genome editing 
tool (mode for gene 
modification)
Method for gene modification Outcome Target gene References
SCNT CRISPR/Cas9 (KI) Using pig fetal fibroblasts transfected with Cas9-
sgRNA expression vector + donor DNA containing 
Cre/loxP system
Two male live piglets with mono-allelic MSTN KO 
obtained exhibited enhanced myofiber quantity, but the 
myofiber size remained unaltered
MSTN [71]
SCNT TALENs (indels) Using pig fetal fibroblasts transfected with TALEN 
plasmids
In total, 12 live and two stillborn piglets were 
collected; all fetuses and piglets exhibited 
homozygous GGTA1-null mutation
GGTA1 [72]
SCNT TALENs (indels) Using porcine fetal fibroblasts co-transfected with 
TALEN and hDAF expression plasmids
Six live-born piglets and three stillborn piglets were 
obtained; the piglets showed eight base mono-allelic 
mutations of GGTA1 and hDAF expression
GGTA1 [73]
SCNT CRISPR/Cas9 (indels) Using fetal fibroblast cells transfected with sgRNA-
Cas9 encoding vector
Four live RUNX3 KO piglets with monoallelic mutation 
showed the lack of RUNX3 protein in their internal 
organ system
RUNX3 [74]
SCNT TALENs (indels) Using dermal fibroblasts transfected with TALEN 
plasmids
MSTN KO piglets exhibited a double-muscled 
phenotype, possessing a higher body weight and 
longissimus muscle mass measuring 170% that of wild-
type piglets, with double the number of muscle fibers
MSTN [75]
SCNT TALENs/Cas9 (KI) Using fetal fibroblast cells transfected with Cas9/
sgRNA or TALEN vector + ssODN
Of seven cloned piglets, some expressed human insulin INS [76]
SCNT CRISPR/Cas9 (KI) Using fetal fibroblast cells transfected with sgRNA-
Cas9 encoding vector + ssODN
One cloned stillborn piglet harbored the orthologous 
p.C313Y mutation at the MSTN locus
APP, LRRK2, 
MSTN
[77]
SCNT TALENs (indels) Using ear fibroblasts transfected with TALEN vectors Thirty GGTA1 biallelic KO piglets were successfully 
delivered and grew normally.
GGTA1 [78]
MI CRISPR/Cas9 (KI) Cytoplasmic MI of Cas9 mRNA + sgRNA + ssODN 
toward in vivo fertilized zygotes
Of five piglets delivered alive, three exhibited pigmentary 
disorders with light-colored iris in eye, which was 
observed in patients harboring Sox10 mutations
Sox10 [79]
MI CRISPR/Cas9 (indels) Cytoplasmic MI of sgRNA-Cas9 encoding vector 
toward in vivo fertilized zygotes
Of six healthy fetuses recovered, four exhibited loss of 
α-Gal epitope expression, indicating a biallelic KO of 
GGTA1
GGTA1 [80]
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MI CRISPR/Cas9 (indels) Cytoplasmic MI of Cas9 mRNA + three types of 
sgRNAs toward in vivo fertilized zygotes
Of two live-born piglets delivered, one piglet 
showed biallelic modification of all three genes, 
and another showed biallelic modification of the 
DJ-1 and PINK1 genes and monoallelic mutations of 
parkin gene
Parkin, DJ-1, 
PINK1
[81]
SCNT-MI CRISPR/Cas9 (indels) Cytoplasmic MI of RNP toward SCNT embryos Six fetuses recovered revealed that all fetuses carried 
biallelic edits for the GRB10 gene (6/6, 100%)
GRB10 [82]
SCNT CRISPR/Cas9 (indels) Using kidney fibroblasts transfected with ZFN vectors Two healthy normal females with GGTA1, CMAH 
double KO phenotypes are currently being raised for 
mating
GGTA1, CMAH [83]
MI CRISPR/Cas9 (indels) Cytoplasmic MI of Cas9 mRNA + sgRNA toward 
IVF-derived zygotes
Seventeen live piglets and two stillborn were produced; 
all had mutations in both genes (no pigs with wild-type 
sequence)
RAG2, IL2RG [84]
MI CRISPR/Cas9 (indels) Cytoplasmic MI of Cas9 mRNA + sgRNA toward in 
vivo fertilized zygotes
Eighteen piglets recovered showed either mono- or 
bi-allelic modifications and no wild-type animals; 
NANOS2 KO pigs phenocopied KO mice with male 
specific germline ablation
NANOS2 [85]
SCNT CRISPR/Cas9 (indels) Using fetal fibroblasts transfected with sgRNA and 
Cas9 expression vectors
Six biallelic KO pigs with mutations in ApoE and LDLR 
genes were obtained successfully in a single step.
ApoE, LDLR [86]
SCNT TALENs Using fetal fibroblasts transfected with TALEN 
plasmid
All six live piglets obtained carried biallelic mutations in 
the P53 locus
P53 [87]
SCNT TALEN (indels) Using fetal fibroblasts transfected with TALEN 
plasmid
A total of 18 live piglets were obtained; they showed 
hypermuscular characteristics
MSTN [88]
SCNT CRISPR/Cas9 (indels) Using fetal fibroblasts transfected with sgRNA-Cas9 
encoding vectors
A total of 37 PERV-inactivated piglets were generated; 
15 piglets remain alive
PERV [89]
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Method Genome editing 
tool (mode for gene 
modification)
Method for gene modification Outcome Target gene References
SCNT CRISPR/Cas9 (indels) Using fetal fibroblasts transfected with sgRNA-Cas9 
encoding vectors
Of 26 female piglets delivered, 23 piglets carried 
mutations in the MSTN locus; the bi-allelic KO pigs 
were viable and exhibited partial double-muscled 
phenotype
MSTN [90]
SCNT CRISPR/Cas9 (KI) Using fetal fibroblasts transfected with Cas9-gRNA 
plasmid and targeting vector
Twelve male piglets were born and expressed UCP1 in a 
tissue-specific manner
UCP1 [91]
MI CRISPR/Cas9 (KI) Cytoplasmic MI of RNP toward in vivo fertilized 
zygotes
A total of 18 fetuses/born piglets were obtained; 
successful insertion of pseudo attP sites within the 
COL1A locus was observed
COL1A [92]
MI CRISPR/Cas9 (indels) Cytoplasmic MI of Cas9 mRNA + sgRNAs toward in 
vivo-derived zygotes
Indels in 92–100% of the embryos analyzed; all 
resulting 12 piglets had biallelic edits of TMRPSS2
TMPRSS2 [93]
MI CRISPR/Cas9 (indels) Direct pronuclear microinjection of Cas9-gRNA 
plasmid
Of seven born piglets, one exhibited biallelic KO 
phenotype and one did monoallelic KO one
GGTA1 [94]
MI CRISPR/Cas9 (indels) Cytoplasmic MI of Cas9 mRNA and dual sgRNAs 
toward in vivo fertilized zygotes
Of nine fetuses examined, three exhibited bi-allelic 
mutations at the PDX1 locus; in those fetuses pancreatic 
primordium was highly disorganized
PDX1 [95]
SCNT 
(Handmade 
cloning)
CRISPR/Cas9 (indels) Using fetal fibroblasts transfected with sgRNA and 
Cas9 expression vectors
Eleven live bi-allelic GGTA1/CMAH double KO piglets 
were obtained with the identical phenotype
GGTA1, CMAH [96]
EP CRISPR/Cas9 Using Cas9 protein and sgRNA (RNP) toward IVF-
derived zygotes
Of 11 piglets born, nine survived; six of nine carried 
mutations in TP53; three of the genome-edited pigs 
(50%) exhibited various tumor phenotypes
TP53 [97]
SCNT CRISPR/Cas9 (KI) Using fetal fibroblasts transfected with sgRNA- Cas9 
plasmid + donor DNA
Three piglets born grew and developed normally; all 
these piglets had fat-1 KI at the Rosa26 locus
Rosa26 [98]
SCNT CRISPR/Cas9 (KI) Using fetal fibroblasts transfected with sgRNA- Cas9 
plasmid + donor DNA
Of seven naturally delivered piglets, six showed 
successful KI; the KI allele was successfully transmitted 
through germline
HTT [99]
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SCNT CRISPR/Cas9 (indels) Using fetal fibroblasts transfected with sgRNA- Cas9 
plasmid
Of a total of 17 piglets obtained, 12 appeared healthy; all 
had mutations at the target locus
FBXO40 [100]
Abbreviations: APC, adenomatous polyposis coli; Alb, albumin; GGTA1, α-1,3-galactosyltransferase gene; APP, amyloid precursor protein; ApoE, apolipoprotein E; ASGR1, asialoglycoprotein receptor; 
β4GalNT2, β1,4-N-acetylgalactosaminyl transferase; class I MHC, class I major histocompatibility complex; CRISPR/Cas9, clustered regulated interspaced short palindromic repeat and CRISPR-associated 
Cas; COL1A, collagen type I alpha 1 chain; CMAH, cytidine monophosphate-N-acetylneuraminic acid hydroxylase; DAZL, deleted in azoospermia-like; DM, double muscling; DMD, Duchenne muscular 
dystrophy; PARKIN, E3 ubiquitin ligase PARK2; EP, electroporation; eGFP, enhanced green fluorescent protein; FBXO40, F-box protein 40; FBN1, fibrillin-1; GM, gene-modified; GRB10, growth-hormone 
receptor binding protein-10; H11, Hipp11; hDAF, human decay-accelerating factor; HTT, huntingtin; indels, insertion or deletion of nucleotides; INS, insulin; IL2RG, interleukin-2 receptor gamma; IVF, 
in vitro fertilized; iGb3S, isogloboside 3 synthase; IgM JH, JH region of the pig IgM heavy chain; KI, knock-in; KO, knockout; LRRK2, leucine-rich repeat kinase 2; LDLR, low density lipoprotein receptor; 
MFS, Marfan syndrome; MI, microinjection; SCNT-MI, microinjection following somatic cell nuclear transfer; MITF, Microphthalmia-associated transcription factor; MSTN, myostatin; NANOS2, nanos 
C2HC-type zinc finger 2; fat-1, n-3 fatty acid desaturase; Npc1l1, Niemann-Pick C1-Like 1; PDX-1, pancreas duodenum homeobox 1; DJ-1, PARK7; PARK2, parkin; PPARγ, peroxisome proliferator-
activated receptor-gamma; PERV, porcine endogenous retrovirus; PINK1, PTEN-induced putative kinase 1; RNP, ribonucleoprotein; RUNX3, Runt-related transcription factor 3; sgRNA, single guide RNA; 
ssODN, single-stranded DNA oligonucleotides; SCNT, somatic cell nuclear transfer; Sox10, SRY (sex determining region Y)-box 10; TALENs, transcription activator-like effector nucleases; TMPRSS2, 
transmembrane protease, serine S1, member 2; TYR, tyrosinase; UCP1, uncoupling protein 1; vWF, von Willebrand factor; ZFNs, zinc finger nucleases.
Table 1. 
Summary of production of genome-edited pigs.
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was found that the endogenous NHEJ pathway is effective for inducing mutation 
in a porcine target gene. Furthermore, SCNT using GE cells with the mutated allele 
as a SCNT donor demonstrated that seven of the nine resulting cloned fetuses 
(at Day 12) stopped expressing EGFP. Yang et al. [42] co-transfected porcine 
fibroblasts with ZFN and pcDNA3.1 plasmids (providing neo) by electroporation 
(EP), performed SCNT using these GE cells, and finally obtained peroxisome 
proliferator-activated receptor γ (PPARγ) mono-allelic KO pigs, which are expected 
to generate a porcine cardiomyopathy model. Hauschild et al. [43] attempted to 
destroy GGTA1, an endogenous gene encoding an enzyme required for production 
of a xenogeneic antigen called α-Gal epitope, using ZFNs in porcine fetal cells. 
They found that α-Gal epitope-negative cells with the bi-allelic KO phenotype 
can be efficiently isolated by FACS, and the resultant GE cells have the potential 
to make cloned piglets. Importantly, this experiment suggests that it is possible to 
produce individuals with a bi-allelic KO phenotype with this technology. In other 
words, bi-allelic KO piglets can be directly created without breeding or subcloning, 
which contrasts with past instances where only heterozygous KO piglets have been 
produced through traditional gene targeting. Hauschild et al. [43] also showed that 
neither off-target cleavage nor integration of the ZFN-coding plasmid occurred.
The successful production of genome-edited piglets with bi-allelic KO genotype 
obtained after cytoplasmic MI of in vivo-derived porcine zygotes using either ZFN 
or TALEN mRNA was first reported by Lillico et al. [45]. This MI-based production 
of GE animals was also shown to be successful in mice [101–104].
Hai et al. [52] first demonstrated that GE pigs can be produced using the 
CRISPR/Cas9 system. They performed cytoplasmic MI with Cas9 mRNA and 
sgRNA targeted to von Willebrand factor gene (vWF) to produce a pig model for type 
1 von Willebrand disease. In this study, 10 of 16 resulting piglets had indels with an 
efficiency of 63%, and most pigs contained more than two different alleles, suggest-
ing mono-allelic mutants.
Successful knock-in (KI) of a GOI into the target locus was first reported in 
pigs by Ruan et al. [60] and Peng et al. [63]. Zhou et al. [61] demonstrated the 
production of SCNT-treated piglets with mutations in multiple genes after a single 
transfection.
Fischer et al. [83] first succeeded in producing GE pigs by cytoplasmic MI of a 
Cas9 protein/gRNA complex called a ribonucleoprotein (RNP). Furthermore, GE 
pigs could be efficiently produced by in vitro EP in the presence of RNP [68]. Sheets 
et al. [82] produced GE fetuses by cytoplasmic MI of RNP into oocytes reconsti-
tuted with intact cells using the SCNT technology. By this treatment, they reported 
highly efficient (100%) generation of bi-allelic modification in the resultant cloned 
fetuses. The significance of this approach is be that researchers can obtain GE pigs 
with a defined genetic background, even though the starting oocytes are derived 
from ovaries obtained from a slaughterhouse.
4. Delivery method
For the production of GE pigs, the choice of delivery method for genome editing 
components in porcine zygotes is important. As shown in Table 1, the methods 
for the production of GE pigs achieved by delivering genome editing reagents at 
earlier stages of development can be largely divided into four groups: the first is 
MI of genome editing reagents (in a form of DNA, mRNA or protein) into zygotes 
(Figure 1A); the second is SCNT using GE cells as the SCNT donor (Figure 1B); 
the third is in vitro EP of zygotes in the presence of genome editing reagents 
(Figure 1C); the fourth is MI of genome editing reagents into SCNT-treated 
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embryos reconstituted using a normal cell (Figure 1D). Furthermore, we will 
provide a new approach based on in vitro EP of the SCNT-treated embryos recon-
stituted using a normal cell as the fifth group of methods for possible production 
of GE pigs (Figure 2A). In the following sections, each of these methods are 
described.
4.1 MI
MI is an important tool in the creation of GE piglets. To date, about 30% (17/60) 
of studies (Table 1) have employed this approach. For example, in the case of MI with 
CRISPR/Cas9-related mRNA, a single cytoplasmic MI of 2–10 pL containing 125 ng/
μL Cas9 mRNA and 12.5 ng/μL sgRNA was adopted [62]. Yu et al. [69] employed Cas9 
mRNA (20 ng/μL) and sgRNA (10 ng/μL) mixtures for cytoplasmic MI.
Is MI of these components deleterious to the development of porcine zygotes? 
According to Hai et al. [52], the in vitro developmental efficiencies of embryos 
injected with Cas9 mRNA/sgRNA (~79%) and embryos injected with water (~77%) 
were both very high and comparable with each other, suggesting that the MI and the 
Cas9 mRNA/sgRNA had little effect on early embryonic development. On the con-
trary, Whitworth et al. [51] reported that a higher concentration of sgRNA induces 
toxicity in porcine embryos. According to Whitworth et al. [51], 10 ng/μL of sgRNA 
and Cas9 mRNA are recommended.
Selecting appropriate zygotes also appears to be an important factor in the pro-
duction of GE pigs. For acquisition of viable zygotes, there are at least two methods. 
One is isolation of zygotes from oviducts of a female that has been inseminated, 
hereinafter called “in vivo-derived zygotes,” and the other is acquisition of zygotes 
by in vitro fertilization (IVF) between in vitro matured oocytes (derived from the 
ovaries obtained from the slaughterhouse) and sperm. Generally, it is believed that 
the in vivo-derived zygotes exhibit superior development performance compar-
ing to the IVF-derived zygotes [51, 62]. Indeed, the number of laboratories using 
Figure 1. 
Several methods to create genome-edited pigs. (A) Microinjection (MI)-based method using zygotes.  
(B) Somatic cell nuclear transfer (SCNT)-based method using gene-engineered (GE) cells as a SCNT donor. 
(C) Electroporation (EP)-based method using zygotes. (D) MI-based method using the SCNT-treated embryos.
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IVF-derived zygotes for production of GE pigs is low (~30% (5/17); see Table 1). 
However, acquisition of viable in vivo-derived zygotes is laborious and often associ-
ated with the sacrifice of pregnant females, which appears to be one of the major 
goals for improvement in genetic engineering technology using pigs.
The frequent generation of individuals with mosaic genotypes is also a serious 
problem associated with MI-based GE pig production. Sato et al. [105] demonstrated 
that cytoplasmic MI of parthenogenetically activated porcine embryos (hereinafter 
called “parthenotes”) with Cas9 mRNA + sgRNA caused frequent mosaicism in the 
offspring (blastocysts) with cells with mixed genotype, so-called normal wild-type 
cells and mutated cells, when they were subjected to cytoplasmic MI immedi-
ately after oocyte activation. Notably, Carlson et al. [44] suggested that 100% of 
bovine embryos exhibited fluorescence expression after cytoplasmic MI of EGFP 
mRNA, but only ~40% of porcine embryos did. It is probable that an endogenous 
system for translation to protein from mRNA may not be sufficiently established 
in those porcine embryos, especially at the stage immediately after fertilization or 
zygotic activation. Indeed, Sato et al. [106] demonstrated that this mosaicism can 
be partially improved when cytoplasmic MI is performed with oocytes 12 h after 
activation. In contrast, other researchers reported that only 10–20% of MI-treated 
embryos exhibited mosaicism [51, 84]. Notably, Whitworth et al. [51] performed 
cytoplasmic MI with Cas9 mRNA + sgRNA toward fertilized oocytes at 14 h post-
fertilization. In this context, the use of sgRNA and an RNP instead of Cas9 mRNA 
Figure 2. 
A new method for production of genome-edited pigs. (A) EP-based method using the SCNT-treated embryos, 
which is termed “GENTEP.” (B) Experimental outline for checking the validity of GENTEP.
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may be the key to solving this issue of mosaicism, as the Cas9 protein is more rapidly 
translated, folded, and complexed with sgRNAs prior to editing, unlike the Cas9 
mRNA [107–109]. For example, in mice, delivering RNPs into zygotes causes rapid 
genome editing in the target locus, which also maximizes efficiency while minimiz-
ing mosaicism [110–112]. Indeed, Sheets et al. [82] demonstrated that after MI with 
RNP, 100% of piglets produced had the bi-allelic KO genotype.
Interestingly, Petersen et al. [80] demonstrated that cytoplasmic MI of DNA 
vectors coding for CRISPR/Cas9 targeting the porcine GGTA1 gene enabled biallelic 
knockout of GGTA1 in 7/12 fetuses and piglets (58.3%). As mentioned previously, 
it is difficult to visualize porcine pronuclei at zygote stage under normal conditions 
due to high lipid content in the cytoplasm. Researchers therefore must centrifuge 
them briefly prior to MI. The fact that cytoplasmic MI of DNA vectors can induce 
genome editing at a target locus may be beneficial for researchers, because prepara-
tion of plasmid DNA is easier than that of mRNA, and it is generally more resistant 
against degradation than mRNA. According to Petersen et al. [80], it currently 
remains unknown how the circular DNA plasmid translocates from the cytoplasm 
to the nucleus. They speculate that the SV40 nuclear translocation signal of the 
CRISPR/Cas9 plasmid could play an important role by facilitating nuclear translo-
cation via association with ubiquitous transcription factors.
4.2 SCNT
SCNT using GE cells as an SCNT donor is another way to produce GE pigs. The 
merit of this approach is the use of in vitro cultivated cells such as fetal fibroblasts to 
which various genetic engineering techniques (i.e., introduction of multiple KO, KI, 
and transgenes) can be applied easily. After gene transfer, these cells are subjected 
to cell selection through drug selection or fluorescence activated cell sorting (FACS) 
to enrich GE cells as a pure population. Thus, it is highly probable that the resulting 
SCNT-derived GE founder pigs have a predictable genotype and low rates of mosa-
icism. Unfortunately, as mentioned previously, the efficiency of SCNT to produce 
cloned piglets is still very low. Much effort has been focused on improving the low 
efficiency associated with the SCNT, which includes improvement of the oocyte/
zygote culture system and application of chemical reagents to alter the epigenetic 
status of transferred nuclei. For improving the culture method, researchers have used 
vitamin C [113], α-tocopherol [114], melatonin [115] or alanyl-glutamine dipeptide 
(instead of glutamine) [116]. For altering the epigenetic status, researchers have 
used histone deacetylase inhibitors (HDACi) such as trichostatin A (TSA) [117, 118], 
valproic acid (VPA) [119–121], scriptaid [122–124], LBH589 (panobinostat) [125], 
oxamflatin [126], PXD101 (belinostat) [127], quisinostat [128], MGCD0103 [129], or 
histone methyltransferase inhibitors such as MM-102 [130]. Lin et al. [131] employed 
tauroursodeoxycholic acid (TUDCA), an inhibitor of endoplasmic reticulum (ER) 
stress, and demonstrated that TUDCA can enhance the developmental potential of 
porcine SCNT embryos by attenuating ER stress and reducing apoptosis. Wang et al. 
[132] demonstrated that administration of siRNA or microRNA-148a, both of which 
can suppress the function of DNA methyltransferase 1 (DNMT1) at a transcriptional 
level, is effective for enhancing the developmental potential of SCNT embryos. 
Furthermore, Matoba et al. [133] succeeded in drastically increasing SCNT efficiency 
by cytoplasmic MI of mRNA coding for histone demethylase (Kdm4d) in mice.
4.3 EP
EP is known to be a useful and powerful gene delivery tool enabling transfer of 
exogenous substances (i.e., DNA) into a cell and was first applied to rat zygotes for 
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genome editing by Kaneko et al. [134]. Since then, many researchers have success-
fully induced gene edits by using this technology in mice [135, 136], bovines [137] 
and pigs [68]. The merit of this technology is that it is simple, rapid and convenient 
for genome editing in zygotes, compared to the previous MI-based technique. 
Notably, about 30–50 zygotes can be edited with one pulse of EP. Furthermore, 
EP only requires a square pulse generator called an electroporator, and not a more 
expensive micromanipulator system.
As mentioned previously, Tanihara et al. [68] first applied EP to porcine IVF-
derived zygotes and produced genome-edited pigs. They used CRISPR/Cas9-based 
RNP for knock-in of a target gene, and achieved reduced mosaicism and higher effi-
ciency of genome-edited pig production with EP (30 V, square pulse 1.0 ms in duration 
repeated five times) using an electrode (#LF501PT1-20; BEX Co. Ltd., Tokyo, Japan) 
connected to a CUY21EDIT II electroporator (BEX Co. Ltd.). Notably, they reported 
no appreciable reduction in the developmental ability of the EP-treated embryos.
4.4 MI after SCNT
Although direct modification of zygotic genomes provides some advantages, 
SCNT also provides a significant advantage by permitting the isolation of cells con-
taining precise modifications before the expense of animal production is incurred. 
As mentioned previously, Sheets et al. [82] successfully produced genome-edited 
cloned pigs by combining SCNT with CRISPR/Cas9 MI, which is beneficial for 
researchers as they do not need to manage a founder herd, and can eliminate the 
need for laborious in vitro culture and screening. In this study, all (6/6) of the resul-
tant clone fetuses exhibited 100% bi-allelic modification. Unfortunately, they failed 
to describe successful production of live birth piglets, but it seems that this approach 
is a powerful tool for GE pig production.
4.5 EP after SCNT
Similar to the approach shown by Sheets et al. [82], we tried to obtain cloned GE 
piglets through in vitro EP in the SCNT-treated embryos, which is called Genome 
Editing via Nuclear Transfer and subsequent Electroporation or GENTEP (Figure 2A). 
Some results obtained from GENTEP-related experiments are presented below.
SCNT-derived embryos were obtained by inserting fetal fibroblasts derived from 
microminiature pigs (MMP) [138] into the perivitelline space between enucleated 
porcine oocytes (derived from ovaries obtained from a slaughterhouse) and zona 
pellucida, according to the method described by Miyoshi et al. [119] (Figure 2B). 
The resulting SCNT-derived embryos were then subjected to electric activation 
following electric fusion between an egg and a cell (Figure 2B). Six or 12 h after 
activation, the SCNT-treated embryos were subjected to in vitro EP in the pres-
ence of RNP targeted to the pig low density lipoprotein receptor (LDLR) gene 
(Figure 2B). Parthenotes (~6 h after electric activation) were also used for in vitro 
EP using tetramethylrhodamine-labeled dextran 3 kDa (used as an indicator for 
successful gene delivery) (as shown in Figure 3A) or as controls for immunocyto-
chemistry using anti-LDLR antibody (as shown in Figure 3B).
First, we examined whether the in vitro EP we used here is effective for suc-
cessful gene delivery to porcine embryos and does not cause any deleterious effects 
on their embryonic development, using porcine parthenotes (6 h after activa-
tion). The EP procedure was based on the method described by Hashimoto and 
Takemoto [135]. An electroporation chamber (#LF610P4-4_470; BEX Co. Ltd.), 
in which two platinum block electrodes were situated with a 1-mm gap between 
them (Figure 1C), was placed under a stereoscopic microscope and connected to 
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an electric pulse generator (CUY21EDITII Genome Editor™, BEX Co. Ltd.). About 
20 parthenotes were placed into a 5-μL drop containing 2 μg/μL tetramethylrhoda-
mine-dextran 3 kDa (#D3307; Thermo Fisher Scientific Inc., Waltham, MA, USA) 
in Opti-MEM (Invitrogen, Carlsbad, CA, USA) between the electrodes (Figure 1C). 
EP was performed under these conditions: 30 V, square pulses, 1.0 ms in duration 
at 99 ms intervals, repeated seven times. The EP-treated parthenotes were then 
cultured for 7 days up to blastocysts to evaluate the in vitro developmental rate and 
uptake of fluorescent dye into the embryos. Approximately 40% of the EP-treated 
parthenotes developed to the blastocyst stage and ~80% of them exhibited bright 
tetramethylrhodamine-derived fluorescence [arrows in Figure 3A(a,b)]. This result 
suggests that our EP condition is useful for effective delivery of a foreign substance 
into porcine embryos and not harmful for their development.
Second, we performed CRISPR/Cas9-based genome editing (targeted to the 
endogenous LDLR gene) with porcine SCNT-treated embryos. We designed sgRNA 
capable of recognizing a 20 bp sequence spanning the translation initiation codon 
(ATG) upstream of the protospacer adjacent motif (PAM) sequence (CGG) on the 
Figure 3. 
Validity check of GENTEP. (A) EP of parthenotes (6 h after activation) in the presence of 
tetramethylrhodamine-labelled dextran 3 kDa. Porcine parthenotes were subjected to in vitro EP, and then 
cultured for 7 days up to blastocysts. Note that almost all of the EP-treated blastocysts are fluorescent (arrows 
in a and b), while intact parthenotes do not fluoresce (c and d). Bar = 100 μm. (B) Staining with anti-LDLR 
antibody. The intact parthenote (hatched blastocysts) exhibits the reactivity to the antibody (arrowheads 
in a–c), but not to the second antibody alone (arrowheads in d–f). No reactivity to the antibody was also 
seen in the GENTEP-derived blastocyst (arrowheads in g–i). Nuclear staining with DAPI was performed 
after staining with the second antibody. Note that porcine zona pellucida was slightly stained with the second 
antibody, since it was found to be reactive with the second antibody alone (see d–f). Bar = 100 μm.
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first exon of porcine LDLR (left panel of Figure 4A). The sgRNA was synthesized 
by Integrated DNA Technologies, Inc. (IDT; Coralville, Iowa, USA) as Alt-R™ 
CRISPR crRNA product. The crRNA and tracrRNA (purchased from IDT) were 
combined for annealing and then mixed with recombinant Cas9 protein (TaKaRa 
Shuzo Co. Ltd., Shiga, Japan) to form RNP, according to the method of Ohtsuka 
et al. [139]. The final concentrations of the components in RNP were 30 μM/mL (for 
crRNA/tracrRNA) and 1 mg/mL (for Cas9 protein). The SCNT-treated embryos 6 
or 12 h after activation were transferred to a 5-μL drop (containing RNP in Opti-
MEM) and immediately subjected to in vitro EP under these conditions: 30 V, 
square pulses, 1.0 ms in duration at 99 ms intervals (or 0.5 ms in duration at 99.5 ms 
intervals), both repeated seven times. After EP, the embryos were promptly culti-
vated in normal medium for 7 days up to blastocysts and then subjected to analysis 
of molecular biology (possible mutations in the first exon of LDLR) and immuno-
cytochemistry (possible loss of LDLR protein synthesis) parameters, as described 
Figure 4. 
Molecular biological analysis of the GENTEP-treated embryos (termed GENTEP-1 to -11) at a single embryo 
level. (A) Structure of porcine LDLR gene and a target sequence recognized by sgRNA (left panel), and the 
results of nested PCR (right panel). The target sequence (shown in blue) spanning ATG (shown in red) is 
located on the first exon of LDLR. PAM, protospacer adjacent motif. Primers used for first PCR and nested 
PCR are shown above the LDRL. In the right panel, a part of the nested PCR products (lanes 1–9) loaded 
onto 2% agarose gel is shown. Arrow indicates the PCR products of 355 bp in size. M, 100-bp ladder markers. 
(B) Ideogram pattern in the GENTEP-1 and -2 samples obtained after direct sequencing of the nested PCR 
products using LDLR-2S primer. (C) Various indels found in each GENTEP-treated embryo. ATG is shown in 
red. Sequence recognized by sgRNA is shown in blue.
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in Figure 2B. In each group, 8–17% of the EP-treated embryos developed to blasto-
cysts (Table 2). These rates appear to be comparable to the yield (24.2%) in experi-
ments performed using intact MMP fetal fibroblasts as SCNT donors [119]. All of 
the blastocysts obtained were then fixed with 4% paraformaldehyde, and a section 
of these embryos was subjected to immunocytochemical staining using anti-LDLR 
antibody (Figure 2B). The EP-treated cloned blastocyst (termed GENTEP-1) was 
unreactive to anti-LDLR (arrows in Figure 3B(g–i)). In contrast, a parthenote 
(blastocyst) exhibited positive reactivity to anti-LDLR (arrow in Figure 3B(a–c)). 
Staining with the second antibody alone failed to react with the antibody (arrow 
in Figure 3B(d–f )). Furthermore, each of these fixed blastocysts was subjected to 
genomic DNA isolation to examine possible mutations at the individual embryo 
level (Figure 2B). Next, GenomiPhi-based whole genome amplification (WGA) 
was performed using the isolated genomic DNA as a template, as described previ-
ously [140]. PCR was then performed using the WGA products as a PCR template. 
The primer sets used are LDLR-S (5′-AAACCTCACATTGAAATGCTG-3′)/
LDLR-RV (5′-CCTAAACTCTCGCGCCCCCCT-3′) for the first round of 
PCR and LDLR-2S (5′-CTGCAAATGACTGGGGCCCCG-3′)/LDLR-2RV 
(5′-CTCCAACCACGTAAGAATGAC-3′) for nested PCR (left panel of Figure 4A). 
Nested PCR using the LDLR-2S/LDLR-2RV primer set yields 355-bp products (left 
panel of Figure 4A). The typical example when the nested PCR products (lanes 
1–9) are loaded onto a 2% agarose gel is shown in the right panel of Figure 4A. 
Almost all of the samples tested exhibited 355-bp products, except for lane 3 
showing bands of reduced size, suggesting occurrence of a large deletion (probably 
over 100 bp) around the LDLR sequence recognized by sgRNA. In Figure 4B, an 
example of the results obtained from direct sequencing of nested PCR products 
using LDLR-2S primer is shown. The sample GENTEP-1, which has been shown to 
exhibit loss of the reactivity to anti-LDLR (see Figure 3B-g-i), had a large deletion 
including a sequence spanning ATG and PAM. Notably, there was no appreciable 
overlapping in ideograms of the sample, suggesting a homozygous bi-allelic KO 
phenotype (Figure 4C). Subcloning of the PCR products derived from the sample 
GENTEP-1 into TA cloning vector and subsequent sequencing demonstrated that 
all six clones obtained exhibited the same sequence as the parental product (data 
not shown). When the remaining PCR products were sequenced it was found 
that almost all (82%, 9/11) of the samples exhibited the homozygous bi-allelic KO 
genotype (Figure 4C).
Stage at EP after 
activation of SCNT-
treated embryos
EP 
condition2
Total number of 
SCNT-treated 
embryos examined
No. of embryos 
cleaved to the two-
cell stage (%)
No. of embryos 
developed to 
blastocysts (%)
6 h 0.5 12 8 (66.7) 1 (8.3)
1.0 12 11 (91.7) 2 (16.7)
12 h 0.5 33 21 (63.6) 5 (15.2)
1.0 35 23 (65.7) 3 (8.6)
1EP in the presence of RNP [10 μM of crRNA/tracrRNA mixture (targeted to LDLR gene) + 0.3 μg/μL of Cas9 
protein] is performed on SCNT-treated embryos 6 or 12 h after activation. The EP-treated embryos were then 
cultured for 7 days to the blastocyst stage for the presence of mutations in the target gene at molecular biological and 
immunocytochemical levels.
2EP was performed under the electric condition of 30 V in voltage, 0.5 ms in length of square pulse with 99.5-ms 
intervals (0.5) or 1.0 ms in length of square pulse with 99-ms intervals (1.0), and seven times of pulse stimulation 
using an electroporation chamber (#LF610P4-4_470; BEX Co. Ltd.) connected to an electric pulse generator 
(CUY21EDITII. Genome Editor™, BEX Co. Ltd.).
Table 2. 
Summary of the properties of blastocysts derived from EP1 toward the SCNT-treated porcine embryos.
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5.  Other techniques and factors affecting efficacy of the genome  
editing system
As shown above, genome editing tools such as ZFNs, TALENs and CRISPR/Cas9 
are considered useful in enabling site-specific gene modification in livestock such as 
pigs. However, there are still several techniques and factors that influence perfor-
mance which must be addressed. These include the single embryo assay, off-target 
cutting, multiplexed genome engineering, KI, and Cas9 pigs. In this section, these 
techniques or factors are described in greater detail.
5.1 Single embryo assay
To increasing the efficiency of genome editing systems, it is important to select 
suitable sets of ZFNs (or TALENs) or sgRNA (in the case of CRISPR/Cas9). Researchers 
therefore must check the efficiency of these reagents by introducing them into cultured 
cells, but at this point it remains unknown whether they will function in vivo. Unlike 
small animals such as mice and rats, large animals have long gestation periods and it is 
costly to prepare large animal recipients. Therefore, this testing in vivo appears to be dif-
ficult in larger animals such as pigs. To overcome this issue, a single embryo (blastocyst) 
assay to evaluate the operability of the genome editing reagents prepared was provided 
by Wang et al. [62] who later re-validated those sets using porcine parthenotes. To 
our knowledge, this assay was first developed using mice by Sakurai et al. [141] who 
reported that it is useful for confirming the fidelity of sgRNAs used.
It may be required to confirm at a molecular level whether the genome-edited 
embryos have mutations. In this case, WGA has often been employed for amplifying 
the whole genome of an embryo (blastocyst) using genomic DNA isolated from a 
single embryo as the DNA template [140, 141], since the blastocyst DNA is often too 
small to generate a sufficient amount of PCR product. The effectiveness of WGA-
based amplification of blastocyst DNA has already been confirmed by ours [142] 
and others [44]. The resulting products obtained after PCR using WGA-derived 
DNA as the template are then subjected to direct sequencing for identification of 
possible mutations in the target gene, as shown in Figure 4B.
5.2 Off-target cleavage
Since sgRNA used in the CRISPR/Cas9 system can recognize only a short 
sequence (20 bp) at the target gene where Cas9 cleaves, other genes with a similar 
sequence to the sgRNA may be susceptible to Cas9-mediated DNA cleavage, which 
leads to the occasional generation of off-target cutting [29, 143]. This unintended 
cutting is considered a serious problem to be resolved.
Several strategies to minimize off-target cutting have been employed including 
the use of the double nickase mutant form of Cas9, which induces a single-strand 
break instead of DSB [144]; the use of RNP, whose half-life is shorter than the dura-
tion of transcription of plasmid or viral nucleic acids [110, 145]; or the fusion of 
catalytically inactive Cas9 with Fok I nuclease domain (fCas9) to improve the DNA 
cleavage specificity [146]. Recently, it was reported that Cpf1, a putative Class 2 
CRISPR effector, mediates target DNA editing differently from Cas9 [147]. It gener-
ates a 5-nucleotide staggered cut with a 5′ overhang, which is particularly advanta-
geous in facilitating an NHEJ-based KI into a genome. Several unique enzymes that 
can decrease the probability of off-target cleavage have also been produced. For 
example, two engineered enzymes produced from SpCas9 from Streptococcus pyo-
genes with the goal of enhancing specificity, called eSpCas9 [148] and SpCas9-HF 
[149], are reported to reduce the probability of mismatched DNA binding. A hybrid 
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enzyme combining the Cas9-nickase and PmCDA1, an activation-induced cytidine 
deaminase (AID) ortholog, could perform targeted nucleotide substitution [150]. 
Furthermore, a CRISPR system using a new Cas-related enzyme called Cas13a that 
targets RNA has also been recently developed [151].
Notably, in the case of GE pigs and embryos, there have been no reports of off-
target mutagenesis as shown by the following papers: [43, 50, 61–64, 69, 74, 77, 78, 80, 
86, 100, 105]. This suggests a very low probability of off target-cleavage in GE pigs.
5.3 Multiplexed genome engineering
The CRISPR/Cas9 system can confer multigene KO in one shot of gene delivery  
[152, 153]. This property is especially beneficial for the purpose of creating disease 
model animals, as certain types of diseases are known to be caused by multigene 
defects. Interestingly, Sakurai et al. [154] demonstrated that at least nine endogenous 
genes can be knocked out simultaneously through a single shot of cytoplasmic MI of 12 
sgRNAs together with Cas9 mRNA into murine zygotes. In pigs, Zhou et al. [61] dem-
onstrated successful generation of PARK2 (parkin) and PTEN-induced putative kinase 
1 (PINK1) double-KO pigs through SCNT with GE fetal fibroblasts after co-transfection 
of Cas9, PARK2-sgRNA, and PINK1-sgRNA-expressing vectors by electroporation. The 
percentage of PARK2−/−/PINK1−/− double-KO cells was up to 38.1%. SCNT using these 
double-KO cells resulted in the birth of 20 cloned piglets. Of these, four piglets devel-
oped normally, and both parkin and PINK1 in those individuals were depleted at the 
protein level. Estrada et al. [66] also succeeded in obtaining one triple-KO cloned piglet 
with mutations in GGTA1 (coding for α-1,3-galactosyltransferase), CMAH (coding for 
cytidine monophosphate-N-acetylneuraminic acid hydroxylase) and β4GalNT2 (cod-
ing for β1,4-N-acetylgalactosaminyl transferase) after SCNT. Wang et al. [81] generated 
PARK7 (DJ-1)/parkin/PINK1 triple-gene modified pigs using the CRISPR/Cas9 system 
in one step through direct zygote injection of Cas9 mRNA and three types of sgRNAs. 
According to Wang et al. [81], of two live-born piglets delivered, one piglet showed 
biallelic modification of all three genes, and another showed biallelic modification of 
the DJ-1 and PINK1 genes and monoallelic mutation of the parkin gene.
5.4 KI
As shown in Table 1, in 2015 successful KI in pigs was reported by several 
groups. For example, Wang et al. [62] performed MI with in vivo fertilized zygotes 
(derived from colored pigs) using Cas9 mRNA + sgRNA + single-stranded DNA 
oligonucleotides (ssODN), targeting microphthalmia-associated transcription fac-
tor (MITF), a master regulator gene of melanocyte development, and obtained two 
live-born piglets showing the white coat color phenotype over its entire body. Peng 
et al. [63] tried to create KI piglets with a MI approach using a circular vector as 
donor DNA. They designed an sgRNA targeting the starting codon region (includ-
ing the adjacent 5′ and ATG) and generated a targeted fragment (donor for HR) 
with the insert flanked by 1-kb HA on both sides. They performed cytoplasmic MI 
of Cas9 mRNA + in vitro synthesized sgRNA + circular vector containing the target-
ing fragment, and finally obtained 16 live piglets, all of which were found to carry 
the expected KI allele. Notably, they confirmed expression of human albumin (Alb) 
protein generated from the KI allele in the plasma of these cloned pigs. This means 
that expression of a transgene (human Alb as GOI) is possible under the control of 
an endogenous promoter system (in this case, Alb promoter).
Ruan et al. [60] demonstrated production of GE pigs with successful KI of GOI 
into the target Hipp11 (H11) locus, which is considered as “safe harbor” genomic locus 
that allows gene expression without disrupting internal gene function, like the Rosa26 
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locus. They utilized a positive and negative selection method to insert GFP into the 
pH 11 locus in pig fetal fibroblast cells by electroporation. The targeting donor vector 
(4.2 kb in size) contains a reporter cassette with neo and GFP genes which are flanked 
by a 0.8-kb HA to the H11 locus on each side with the diphtheria toxin A (DTA) gene 
at the 3′ end. Cells were transfected with the linearized donor vector and two expres-
sion vectors for sgRNA (targeted to the H11 locus) and Cas9. After drug selection, 
they obtained GE cells with successful KI at the H11 locus with efficiencies up to 54%. 
Next, they performed SCNT using these correctly targeted clones, and obtained one 
cloned piglet which was later confirmed to show correct targeting.
Generally, it is believed that HDR-mediated KI is more difficult than NHEJ-based 
indels. For example, in proliferating human cells, NHEJ has been reported to repair 
75% of DSBs, while HDR repaired the remaining 25% [155]. To enhance the HDR 
efficiency, several approaches are now being attempted. For examples, co-injection 
of murine zygotes with a mixture containing Cas9 mRNA, sgRNA, template ssODNs 
and Scr7 (an inhibitor for DNA ligase IV) significantly improved the efficiency of 
HDR-mediated insertional mutagenesis [156]. Chu et al. [157] also demonstrated 
usefulness of Scr7 for abolishing NHEJ activity and increasing HDR in both human 
and mouse cell lines. However, the function of Scr7 in promoting HDR remains 
controversial. Some researchers demonstrated that Scr7 failed to increase HDR rates 
in rabbit embryos [158] and porcine fetal fibroblasts [159]. On the contrary, Li et al. 
[160] demonstrated that Scr7 promoted HDR efficiency in porcine fetal fibroblasts. 
The same group also showed that other reagents L755507 (β-3 adrenergic receptor 
agonist) and resveratrol (small-molecule compound found in grapes) also showed 
similar effects (promotion of HDR efficiency) in porcine cells.
5.5 Cas9 pigs
As mentioned previously, the current generation of gene-edited pigs has mostly 
been produced through either MI or SCNT approaches, which are both expensive and 
time-consuming. In mice, several Tg lines carrying a Cas9-expressing cassette have been 
created [154, 161, 162]. These Tg mice are thought to be useful animals for direct in vivo 
genome editing experiments, because successful delivery of the expression vectors of 
sgRNAs alone or RNA itself into selected tissues caused generation of genome-edited 
tissues. For example, Platt et al. [161] demonstrated that in vivo viral administration of 
Kirsten rat sarcoma viral oncogene homolog (Kras), transformation related protein 53 
(Trp53), and serine/threonine-protein kinase 11 (Stk11)-gRNAs to the Cas9-expressing 
line caused lung carcinomas within a short period. This suggests that if a Cas9-
expressing pig is produced, it will provide an easy and efficient way to produce genetic 
modifications, which should substantially facilitate studying gene functions, modeling 
human diseases, and promoting agricultural productivity. Based on this concept, Wang 
et al. [163] first produced Cre-dependent Cas9-expressing pigs to enable efficient in 
vivo genome editing. They first transfected the linear-targeting donor containing Cre-
dependent Cas9-expression cassette and TALEN plasmids directed to Rosa26 locus into 
porcine fetal fibroblasts and finally selected clones carrying KI cassette. These clones 
were then used for SCNT to produce cloned GE piglets. They showed that cells isolated 
from several organs of GE pigs exhibited Cre-induced activation of Cas9 expression. 
This Cas9 pig line will be used for various studies as indicated above.
6. Conclusion
Because pigs are similar to humans in physiological, anatomical, and genetic 
aspects, they are now seen as a leading animal model for biomedical research. Recent 
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advances in genome editing technology have led to accelerated production of GE 
pigs within a relatively short time period, which is beneficial due to cost savings in 
propagation of GE animals and maintaining animals for breeding. Production of 
GE pigs can be largely categorized into two approaches, so-called MI/EP-mediated 
production of GE zygotes and SCNT using GE cells as the SCNT donor. There are 
advantages and drawbacks for both these approaches. For example, the former is 
simpler, more convenient, and cost-effective than the latter. However, the avail-
able genetic background is limited. In this context, the latter is beneficial for the 
flexibility of choosing any type of genetic background, because the genetic back-
ground of SCNT-derived cloned pigs is determined by that of donor cells used for 
SCNT. Unfortunately, the efficiency of SCNT is extremely low at present. MI/EP 
with SCNT-treated embryos may compensate for these disadvantages associated 
with MI/EP or SCNT-mediated production of GE piglets, if the efficiency of SCNT is 
greatly improved in future.
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